Bill
HB 5634
Overview: HB 5634, the Defending Affordable Prescription Drug Costs Act, was signed into law on June 27, 2025.Purpose and Intent: The bill aims to address the rising costs of presc
Overview: HB 5634, the Defending Affordable Prescription Drug Costs Act, was signed into law on June 27, 2025.
Purpose and Intent: The bill aims to address the rising costs of prescription drugs by implementing measures to increase transparency and competition in the pharmaceutical industry.
Key Provisions:
- Requires drug manufacturers to provide advance notice and justification for price increases above a certain threshold
- Establishes a prescription drug affordability board to review and set upper payment limits for certain high-cost drugs
- Prohibits "gag clauses" that prevent pharmacists from informing patients about lower-cost drug options
- Allows the state to import certain prescription drugs from Canada to increase access to affordable medications
Affected Parties and Impacts: The bill is expected to benefit consumers by lowering out-of-pocket costs for prescription drugs. It will also impact drug manufacturers, pharmacies, and the state's healthcare system.
Procedural and Timeline Considerations: The bill was signed into law and will go into effect on January 1, 2026, with the prescription drug affordability board established within 6 months.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
